compounded tirzepatide with pyridoxine Lipo-C and Together: Safety Guide Done with week 14 💪🏽

Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, et al

This strategic move aligns with the potential of GLP-1 agonists in weight loss, underscored by the recent FDA approval of Zepbound for obesity treatment

Get Individualized Side-Effect Coaching With Healthon Navigating the side effects of GLP-1 medications doesn't have to be a solo journey

Release Date: 5/14/2024

Some people may qualify for savings programs or manufacturer discounts, while others may need to explore other more cost-effective options

The GLP-1 wave (semaglutide, tirzepatide) has created unprecedented demand for peptide API manufacturing, and the companies that build credible, scaled peptide capabilities over the next 2-3 years will unlock the largest single growth opportunity in pharmaceutical manufacturing